Yeşim İŞLER
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yeşim İŞLER has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Halil Kaya
Department of Emergency Medicine, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16310, Türkiye
23 shared publications - Melih Yüksel
Department of Emergency Medicine, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16310, Türkiye
20 shared publications - Mehmet Oguzhan Ay
Department of Emergency Medicine, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16310, Türkiye
15 shared publications Halil Kaya
Department of Emergency Medicine, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Türkiye
5 shared publications- Umut Ocak
Loma Linda University School of Medicine
4 shared publications Mehmet Oğuzhan Ay
Department of Emergency Medicine, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Türkiye
3 shared publications
Latest Publications
- Open Access
Clinical Characteristics of Vaccinated and Unvaccinated Patients Who Died from COVID-19: A Retrospective Comparative Study
Background: Fatal COVID-19 cases continued to occur after the introduction of vaccination, particularly among older adults and individuals with chronic comorbidities. This study aimed to describe and compare the demographic and clinical characteristics of vaccinated and unvaccinated adults who died from COVID-19. Methods: This single-center retrospective comparative study included 1525 adults who died from RT-PCR-confirmed COVID-19 during hospitalization between January 2021 and June 2022. Patients were classified according to documented prior vaccination status. Demographic characteristics, comorbidities, vaccine dose number, and vaccination regimens were evaluated. Multivariable logistic regression was used to examine associations between demographic and clinical characteristics and prior vaccination status within this fatal-case population. Results: Of 1525 patients, 364 (23.9%) had documented prior vaccination and 1161 (76.1%) were unvaccinated. Patients with prior vaccination were older than unvaccinated patients (median age, 77 vs. 70 years; p < 0.001) and more frequently had at least one comorbidity (84.1% vs. 66.2%; p < 0.001). In multivariable analysis, older age, hypertension, heart failure, COPD/asthma, and malignancy were independently associated with prior vaccination status. Coronary artery disease showed a borderline association (OR, 1.330; 95% CI, 0.997–1.775; p = 0.052). The model showed modest discrimination (AUC = 0.662) and limited explained variance (Nagelkerke R2 = 0.089). Conclusions: Among patients who died from COVID-19, those with documented prior vaccination were older and had a greater burden of several comorbidities than unvaccinated decedents. Because this case-only analysis was restricted to fatal cases and lacked surviving comparison groups and population denominators, the observed associations should be interpreted as descriptive characteristics of the study population and not as estimates of mortality risk or vaccine effectiveness. Differences between vaccination groups may also reflect vaccination prioritization and selection processes inherent in conditioning the analysis on death.
Open AccessClinical Characteristics of Vaccinated and Unvaccinated Patients Who Died from COVID-19: A Retrospective Comparative Study
Background: Fatal COVID-19 cases continued to occur after the introduction of vaccination, particularly among older adults and individuals with chronic comorbidities. This study aimed to describe and compare the demographic and clinical characteristics of vaccinated and unvaccinated adults who died from COVID-19. Methods: This single-center retrospective comparative study included 1525 adults who died from RT-PCR-confirmed COVID-19 during hospitalization between January 2021 and June 2022. Patients were classified according to documented prior vaccination status. Demographic characteristics, comorbidities, vaccine dose number, and vaccination regimens were evaluated. Multivariable logistic regression was used to examine associations between demographic and clinical characteristics and prior vaccination status within this fatal-case population. Results: Of 1525 patients, 364 (23.9%) had documented prior vaccination and 1161 (76.1%) were unvaccinated. Patients with prior vaccination were older than unvaccinated patients (median age, 77 vs. 70 years; p < 0.001) and more frequently had at least one comorbidity (84.1% vs. 66.2%; p < 0.001). In multivariable analysis, older age, hypertension, heart failure, COPD/asthma, and malignancy were independently associated with prior vaccination status. Coronary artery disease showed a borderline association (OR, 1.330; 95% CI, 0.997–1.775; p = 0.052). The model showed modest discrimination (AUC = 0.662) and limited explained variance (Nagelkerke R2 = 0.089). Conclusions: Among patients who died from COVID-19, those with documented prior vaccination were older and had a greater burden of several comorbidities than unvaccinated decedents. Because this case-only analysis was restricted to fatal cases and lacked surviving comparison groups and population denominators, the observed associations should be interpreted as descriptive characteristics of the study population and not as estimates of mortality risk or vaccine effectiveness. Differences between vaccination groups may also reflect vaccination prioritization and selection processes inherent in conditioning the analysis on death.
- 2 August 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (10) , 3106-3115
Comparison of Alvarado, RIPASA , AIR and Tzanakis Scores in Acute Appendicitis: Prediction of Complicated Disease
Background: Acute appendicitis (AA) is one of the most common causes of acute abdominal pain requiring emergency surgery. This study compared the diagnostic accuracy of the Alvarado, Raja Isteri Pengiran Anak Saleha Appendicitis (RIPASA), Appendicitis Inflammatory Response (AIR) and Tzanakis scoring systems in patients undergoing appendectomy for suspected AA, with emphasis on predicting complicated appendicitis. Methods: This prospective observational study was conducted at the University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital between June 2021 and February 2022. Patients consecutively undergoing appendectomy for suspected AA were enrolled. Clinical, laboratory and imaging data were prospectively collected and all four scores calculated at emergency department evaluation. Diagnostic performance was assessed by ROC curve analysis, with histopathological examination as the reference standard. Results: A total of 303 patients were included; 193 (63.7%) were male, with a median age of 33 years (IQR: 24–43). AA was confirmed in 296 patients (97.7%), with perforated appendicitis in 53 (17.5%) and plastron appendicitis in 20 (6.6%). Alvarado, RIPASA and AIR scores were significantly higher in confirmed appendicitis ( p < 0.001 for all). AUC values were 0.850, 0.878 and 0.871, respectively, with no significant difference among these three systems. The AIR score achieved the highest AUC of 0.754 for predicting perforated appendicitis, outperforming all other systems. Conclusion: The Alvarado, RIPASA and AIR scoring systems demonstrated comparable diagnostic performance for AA. The AIR score showed a superior ability to predict complicated appendicitis preoperatively, supporting its role in risk stratification and clinical decision‐making in the emergency department.
- 2 August 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (10) , 3106-3115
Comparison of Alvarado, RIPASA , AIR and Tzanakis Scores in Acute Appendicitis: Prediction of Complicated Disease
Background: Acute appendicitis (AA) is one of the most common causes of acute abdominal pain requiring emergency surgery. This study compared the diagnostic accuracy of the Alvarado, Raja Isteri Pengiran Anak Saleha Appendicitis (RIPASA), Appendicitis Inflammatory Response (AIR) and Tzanakis scoring systems in patients undergoing appendectomy for suspected AA, with emphasis on predicting complicated appendicitis. Methods: This prospective observational study was conducted at the University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital between June 2021 and February 2022. Patients consecutively undergoing appendectomy for suspected AA were enrolled. Clinical, laboratory and imaging data were prospectively collected and all four scores calculated at emergency department evaluation. Diagnostic performance was assessed by ROC curve analysis, with histopathological examination as the reference standard. Results: A total of 303 patients were included; 193 (63.7%) were male, with a median age of 33 years (IQR: 24–43). AA was confirmed in 296 patients (97.7%), with perforated appendicitis in 53 (17.5%) and plastron appendicitis in 20 (6.6%). Alvarado, RIPASA and AIR scores were significantly higher in confirmed appendicitis ( p < 0.001 for all). AUC values were 0.850, 0.878 and 0.871, respectively, with no significant difference among these three systems. The AIR score achieved the highest AUC of 0.754 for predicting perforated appendicitis, outperforming all other systems. Conclusion: The Alvarado, RIPASA and AIR scoring systems demonstrated comparable diagnostic performance for AA. The AIR score showed a superior ability to predict complicated appendicitis preoperatively, supporting its role in risk stratification and clinical decision‐making in the emergency department.
- Open Access
- 24 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5791
Predictive Performance of Trauma Scoring Systems for Mortality in Patients with High-Energy Trauma in the Emergency Department
Background/Objectives: Early identification of high-risk trauma patients is essential for optimizing clinical decision-making and improving outcomes. Several trauma scoring systems are available, but their comparative performance for predicting early and short-term mortality remains uncertain. This study compared the prognostic performance of the Injury Severity Score (ISS), Trauma and Injury Severity Score (TRISS), Rapid Emergency Medicine Score (REMS), and Shock Index for predicting both 24-h and 28-day mortality in patients with high-energy trauma. Methods: This prospective observational study included 277 consecutive adult patients presenting with high-energy trauma to a tertiary emergency department. ISS, TRISS, REMS, and Shock Index were calculated on admission. The primary outcomes were 24-h and 28-day mortality. Discriminatory performance was assessed using receiver operating characteristic (ROC) analysis. Optimal cut-off values were determined using the Youden index, and pairwise ROC comparisons were performed using the DeLong method. An exploratory multivariable logistic regression analysis was conducted to evaluate factors associated with 28-day mortality. Results: The 24-h mortality rate was 1.4% (4/277), whereas the 28-day mortality rate was 5.4% (15/277). For predicting 28-day mortality, TRISS (AUC 0.939, 95% CI 0.898–0.979), REMS (AUC 0.907, 95% CI 0.842–0.971), and ISS (AUC 0.900, 95% CI 0.827–0.973) demonstrated excellent and comparable discrimination, whereas Shock Index showed significantly lower predictive performance (AUC 0.696, 95% CI 0.519–0.874). Pairwise DeLong comparisons demonstrated no significant differences among ISS, TRISS, and REMS, whereas Shock Index performed significantly worse than all three scores. Exploratory multivariable analysis identified antiplatelet therapy, abdominal trauma, head and neck trauma, any comorbidity, and age ≥ 65 years as factors associated with increased odds of 28-day mortality. Conclusions: ISS, TRISS, and REMS demonstrated comparable and excellent performance for predicting 28-day mortality following high-energy trauma, whereas Shock Index showed significantly lower discriminatory ability. REMS may provide a practical bedside tool for early risk assessment, while ISS and TRISS remain valuable for comprehensive prognostic evaluation. Because of the limited number of mortality events, the multivariable analysis should be considered exploratory and requires validation in larger prospective multicenter studies.
- 24 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5791
Open AccessPredictive Performance of Trauma Scoring Systems for Mortality in Patients with High-Energy Trauma in the Emergency Department
Background/Objectives: Early identification of high-risk trauma patients is essential for optimizing clinical decision-making and improving outcomes. Several trauma scoring systems are available, but their comparative performance for predicting early and short-term mortality remains uncertain. This study compared the prognostic performance of the Injury Severity Score (ISS), Trauma and Injury Severity Score (TRISS), Rapid Emergency Medicine Score (REMS), and Shock Index for predicting both 24-h and 28-day mortality in patients with high-energy trauma. Methods: This prospective observational study included 277 consecutive adult patients presenting with high-energy trauma to a tertiary emergency department. ISS, TRISS, REMS, and Shock Index were calculated on admission. The primary outcomes were 24-h and 28-day mortality. Discriminatory performance was assessed using receiver operating characteristic (ROC) analysis. Optimal cut-off values were determined using the Youden index, and pairwise ROC comparisons were performed using the DeLong method. An exploratory multivariable logistic regression analysis was conducted to evaluate factors associated with 28-day mortality. Results: The 24-h mortality rate was 1.4% (4/277), whereas the 28-day mortality rate was 5.4% (15/277). For predicting 28-day mortality, TRISS (AUC 0.939, 95% CI 0.898–0.979), REMS (AUC 0.907, 95% CI 0.842–0.971), and ISS (AUC 0.900, 95% CI 0.827–0.973) demonstrated excellent and comparable discrimination, whereas Shock Index showed significantly lower predictive performance (AUC 0.696, 95% CI 0.519–0.874). Pairwise DeLong comparisons demonstrated no significant differences among ISS, TRISS, and REMS, whereas Shock Index performed significantly worse than all three scores. Exploratory multivariable analysis identified antiplatelet therapy, abdominal trauma, head and neck trauma, any comorbidity, and age ≥ 65 years as factors associated with increased odds of 28-day mortality. Conclusions: ISS, TRISS, and REMS demonstrated comparable and excellent performance for predicting 28-day mortality following high-energy trauma, whereas Shock Index showed significantly lower discriminatory ability. REMS may provide a practical bedside tool for early risk assessment, while ISS and TRISS remain valuable for comprehensive prognostic evaluation. Because of the limited number of mortality events, the multivariable analysis should be considered exploratory and requires validation in larger prospective multicenter studies.
- 2 July 2026
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 138 (7) , 872-879
Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures
Reliable biomarkers reflecting acute seizure activity in patients presenting to the emergency department remain insufficiently defined. This study aimed to compare serum nesfatin-1 levels in patients presenting with epileptic seizures and healthy controls, and to evaluate their associations with clinical, demographic, and inflammatory parameters. This cross-sectional study included 216 participants, comprising 131 patients admitted to the emergency department due to epileptic seizures and 85 age- and sex-matched healthy controls. Demographic characteristics, comorbidities, antiseizure medication use, seizure features, and laboratory parameters were recorded. Serum nesfatin-1 concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Group comparisons were performed using the Mann-Whitney U test, and correlations were analyzed with Spearman's correlation coefficient. Serum nesfatin-1 levels were significantly higher in patients with epileptic seizures compared with controls (p < 0.001). C-reactive protein (CRP) levels were also elevated in the patient group (p < 0.05). Nesfatin-1 concentrations showed positive correlations with age, CRP levels, and seizure duration, and negative correlations with height and body weight (all p < 0.05). Additionally, sex, diabetes mellitus, congestive heart failure, and type of antiseizure medication were significantly associated with circulating nesfatin-1 levels. Serum nesfatin-1 levels are elevated in patients presenting with epileptic seizures and are associated with inflammatory markers, seizure duration, and metabolic parameters. These findings suggest that nesfatin-1 may reflect integrated neuroinflammatory and metabolic responses occurring during acute seizure episodes. Further prospective studies are required to determine its clinical utility and prognostic value.
- 2 July 2026
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 138 (7) , 872-879
Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures
Reliable biomarkers reflecting acute seizure activity in patients presenting to the emergency department remain insufficiently defined. This study aimed to compare serum nesfatin-1 levels in patients presenting with epileptic seizures and healthy controls, and to evaluate their associations with clinical, demographic, and inflammatory parameters. This cross-sectional study included 216 participants, comprising 131 patients admitted to the emergency department due to epileptic seizures and 85 age- and sex-matched healthy controls. Demographic characteristics, comorbidities, antiseizure medication use, seizure features, and laboratory parameters were recorded. Serum nesfatin-1 concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Group comparisons were performed using the Mann-Whitney U test, and correlations were analyzed with Spearman's correlation coefficient. Serum nesfatin-1 levels were significantly higher in patients with epileptic seizures compared with controls (p < 0.001). C-reactive protein (CRP) levels were also elevated in the patient group (p < 0.05). Nesfatin-1 concentrations showed positive correlations with age, CRP levels, and seizure duration, and negative correlations with height and body weight (all p < 0.05). Additionally, sex, diabetes mellitus, congestive heart failure, and type of antiseizure medication were significantly associated with circulating nesfatin-1 levels. Serum nesfatin-1 levels are elevated in patients presenting with epileptic seizures and are associated with inflammatory markers, seizure duration, and metabolic parameters. These findings suggest that nesfatin-1 may reflect integrated neuroinflammatory and metabolic responses occurring during acute seizure episodes. Further prospective studies are required to determine its clinical utility and prognostic value.
- 28 June 2026
- Published by Emergency Medicine Association of Turkey in Anatolian Journal of Emergency Medicine
- Vol. 9 (2) , 91-98
Prognostic Value of Laboratory Biomarkers and Risk Scores in STEMI Patients Presenting to the Emergency Department Undergoing Manual Thrombus Aspiration
Aim: Early risk stratification in the emergency department (ED) is critical for patients presenting with ST-elevation myocardial infarction (STEMI). This study aimed to evaluate the prognostic performance of commonly used clinical risk scores (TREWS, REMS, TIMI, and C-ACS) and readily available laboratory ratios, including the D-dimer/Albumin ratio (DAR) and Blood Urea Nitrogen/Albumin ratio (BAR), for short-term outcomes in STEMI patients presenting to the ED who subsequently underwent manual thrombus aspiration (MTA) during percutaneous coronary intervention (PCI).Material and Methods: This prospective, single-center study included consecutive STEMI patients presenting to the ED between February 2023 and January 2024. Patients who underwent MTA during PCI were analyzed. The ability of clinical scores and laboratory ratios obtained during the initial ED evaluation to predict 28-day all-cause mortality, recurrent acute coronary syndrome (ACS), and stroke was assessed using receiver operating characteristic (ROC) curve analysis.Results: Among 363 STEMI patients, 30 (8.3%) underwent MTA. MTA was more frequently performed in patients with anterolateral and posterolateral STEMI. Significant differences were observed in age, REMS, and C-ACS scores between patients who did and did not undergo MTA. The TIMI score differed significantly across STEMI localization subgroups. BAR demonstrated excellent prognostic performance for 28-day mortality (AUC = 0.889; 95% CI: 0.766–1.000; p < 0.05). None of the evaluated scores or laboratory ratios reliably predicted recurrent ACS or stroke.Conclusion: Among the evaluated laboratory biomarkers and clinical scores, BAR demonstrated the highest prognostic performance for predicting 28-day mortality in STEMI patients undergoing MTA. These findings suggest that BAR, a simple and rapidly available laboratory parameter, may assist emergency physicians in early risk stratification of high-risk STEMI patients, whereas traditional risk scores showed limited utility for predicting short-term non-fatal outcomes.
- 28 June 2026
- Published by Emergency Medicine Association of Turkey in Anatolian Journal of Emergency Medicine
- Vol. 9 (2) , 91-98
Prognostic Value of Laboratory Biomarkers and Risk Scores in STEMI Patients Presenting to the Emergency Department Undergoing Manual Thrombus Aspiration
Aim: Early risk stratification in the emergency department (ED) is critical for patients presenting with ST-elevation myocardial infarction (STEMI). This study aimed to evaluate the prognostic performance of commonly used clinical risk scores (TREWS, REMS, TIMI, and C-ACS) and readily available laboratory ratios, including the D-dimer/Albumin ratio (DAR) and Blood Urea Nitrogen/Albumin ratio (BAR), for short-term outcomes in STEMI patients presenting to the ED who subsequently underwent manual thrombus aspiration (MTA) during percutaneous coronary intervention (PCI).Material and Methods: This prospective, single-center study included consecutive STEMI patients presenting to the ED between February 2023 and January 2024. Patients who underwent MTA during PCI were analyzed. The ability of clinical scores and laboratory ratios obtained during the initial ED evaluation to predict 28-day all-cause mortality, recurrent acute coronary syndrome (ACS), and stroke was assessed using receiver operating characteristic (ROC) curve analysis.Results: Among 363 STEMI patients, 30 (8.3%) underwent MTA. MTA was more frequently performed in patients with anterolateral and posterolateral STEMI. Significant differences were observed in age, REMS, and C-ACS scores between patients who did and did not undergo MTA. The TIMI score differed significantly across STEMI localization subgroups. BAR demonstrated excellent prognostic performance for 28-day mortality (AUC = 0.889; 95% CI: 0.766–1.000; p < 0.05). None of the evaluated scores or laboratory ratios reliably predicted recurrent ACS or stroke.Conclusion: Among the evaluated laboratory biomarkers and clinical scores, BAR demonstrated the highest prognostic performance for predicting 28-day mortality in STEMI patients undergoing MTA. These findings suggest that BAR, a simple and rapidly available laboratory parameter, may assist emergency physicians in early risk stratification of high-risk STEMI patients, whereas traditional risk scores showed limited utility for predicting short-term non-fatal outcomes.
- 30 March 2026
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 105, 11-15
The role of serum subfatin levels in the diagnosis of epileptic seizures: A case-control study
- 30 March 2026
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 105, 11-15
The role of serum subfatin levels in the diagnosis of epileptic seizures: A case-control study
- 27 March 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Investigation of the Relationship Between Serum Subfatin Levels and Clinical Outcomes in Patients with Ischemic Wake-Up Stroke in the Emergency Department
This study aimed to investigate the association between admission serum subfatin levels and 28- and 90-day mortality and functional outcomes (Modified Rankin Scale, mRS) in patients diagnosed with ischemic wake-up stroke in the emergency department. Between April 2022 and March 2023, 66 patients presenting with wake-up stroke and 71 healthy controls were prospectively evaluated. Serum subfatin levels were measured by ELISA in all participants. Mortality and mRS scores at 28 and 90 days were recorded for the patient group. Serum subfatin levels were significantly lower in the patient group compared to controls (median: 1.44 ng/dL vs. 1.65 ng/dL; p0.05). Subfatin levels showed significant differences in patients with anterior cerebral artery and superior cerebellar artery involvement (p<0.05). Serum subfatin levels are lower in patients with ischemic wake-up stroke than in healthy controls. However, no significant relationship was found between subfatin levels and short- or medium-term mortality or functional outcomes. Larger studies are needed to validate these findings.
- 27 March 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Investigation of the Relationship Between Serum Subfatin Levels and Clinical Outcomes in Patients with Ischemic Wake-Up Stroke in the Emergency Department
This study aimed to investigate the association between admission serum subfatin levels and 28- and 90-day mortality and functional outcomes (Modified Rankin Scale, mRS) in patients diagnosed with ischemic wake-up stroke in the emergency department. Between April 2022 and March 2023, 66 patients presenting with wake-up stroke and 71 healthy controls were prospectively evaluated. Serum subfatin levels were measured by ELISA in all participants. Mortality and mRS scores at 28 and 90 days were recorded for the patient group. Serum subfatin levels were significantly lower in the patient group compared to controls (median: 1.44 ng/dL vs. 1.65 ng/dL; p0.05). Subfatin levels showed significant differences in patients with anterior cerebral artery and superior cerebellar artery involvement (p<0.05). Serum subfatin levels are lower in patients with ischemic wake-up stroke than in healthy controls. However, no significant relationship was found between subfatin levels and short- or medium-term mortality or functional outcomes. Larger studies are needed to validate these findings.
- Open Access
- 17 January 2025
- Published by Kare Publishing in Global Emergency and Critical Care
Relationship Between D-dimer/Lymphocyte Ratio and CURB-65 Scores in COVID-19 Pneumonia Prognosis and Mortality
Relationship Between D-dimer/Lymphocyte Ratio and CURB-65 Scores in COVID-19 Pneumonia Prognosis and Mortality - Global Emergency And Critical Care
- 17 January 2025
- Published by Kare Publishing in Global Emergency and Critical Care
Open AccessRelationship Between D-dimer/Lymphocyte Ratio and CURB-65 Scores in COVID-19 Pneumonia Prognosis and Mortality
Relationship Between D-dimer/Lymphocyte Ratio and CURB-65 Scores in COVID-19 Pneumonia Prognosis and Mortality - Global Emergency And Critical Care
- 18 December 2024
- Published by Galenos Yayinevi in Eurasian Journal of Emergency Medicine
- Vol. 23 (4) , 270-277
Factors Influencing Mortality in Patients with Pacemaker/ICD Dysfunction Presenting to Emergency Departments
- 18 December 2024
- Published by Galenos Yayinevi in Eurasian Journal of Emergency Medicine
- Vol. 23 (4) , 270-277
Factors Influencing Mortality in Patients with Pacemaker/ICD Dysfunction Presenting to Emergency Departments